For context, semaglutide (Wegovy) tops out around 15% and tirzepatide (Zepbound) around 20.9%
Semaglutide was associated with a significant reduction on weight loss related outcomes, including the absolute value of weight loss (WMD -897, 95% CI -1073 to -721), percentage of weight loss (WMD -1000, 95% CI -1199 to -800), body mass index (WMD-319, 95% CI -402 to -237) and waist circumference (WMD -721,95% CI -887 to -556)
See Important Safety Information, including Boxed Warning, at ro.co/safety-info/glp1/.
These programs typically start with a short health assessment that a doctor reviews before writing a prescription
CuP demonstrates a wide range of biological activities, including antioxidative properties, inflammatory modulation, chemotactic cell recruitment, and promotion of angiogenesis and cell proliferation 35,36